“23andMe Inc., the Google Inc.-backed DNA analysis company co-founded by Anne Wojcicki, was told by U.S. regulators to halt sales of its main product because it’s being sold without ‘marketing clearance or approval.’ The Saliva Collection Kit and Personal Genome Service, or PGS, tells users whether they carry a disease, are at risk of a disease and would respond to a drug. Most of the uses fall into the category of a medical device and require Food and Drug Administration approval, the agency told the Mountain View, California-based company in a Nov. 22 letter made public today.”
Related posts:
Bradley Manning’s Letter To President Obama Requesting Pardon
Iceland plans "stability tax" at removal of capital controls
UberPOP halts service in France after clampdown, protests
There was a time when kids were taught to respect firearms, not fear them
Bitcoins and bars: Chicagoans getting in on virtual currency
Mass protest in Japan against U.S. hybrid aircraft
Escalating US-China spying war is McKinsey’s loss and Huawei’s gain
Trump slaps tariffs on foreign solar panels and washing machines
Gold Investors Seek Alpine Haven in Swiss Army Bunkers
California man jailed for painting crosswalk
Belarus jails border guard over ‘teddy bear invasion’
Can police collect DNA when someone is arrested? Supreme Court to decide.
Nick Turse Describes the Real Vietnam War
Fannie To Allow Mortgage Walkaways by On-Time Borrowers
Washington state pot regulators favor outdoor growth for environmental reasons